United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 1 minute read Pharma Industry News Restaurant Industry News FDA accepts Ascendis Pharma’s TransCon hGH BLA for pediatric GHD Ascendis Pharma, a Danish biopharma company, said that the US Food and Drug Administration (FDA) has accepted its… bypharmanewsdailySeptember 4, 2020
